Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations

P. Antal-Szalmás, Miriam J J G Poppelier, Andrea Sümegi, Tjomme Van Der Bruggen, Jan Verhoef, Kok P M Van Kessel, Jos A G Van Strijp

Research output: Article

7 Citations (Scopus)

Abstract

Human monocytes express on their plasma membrane relatively large number of CD14 molecules, known to play a crucial role in the lipopolisaccharide (LPS)-mediated cellular activation. Indirect data (J. Biol. Chem. 270 (1995) 9904) suggest that not all of these CD14 molecules participate in LPS-signaling, but the importance of these spare receptors and the exact number of CD14 involved in activation upon different LPS-stimuli is not known. Using different concentrations of a blocking anti-CD14 monoclonal antibody (mAb 60bca) we created monocytes with graded amounts of CD14. The exact number of occupied and free receptors was quantitated by flow cytometry and special mAb-labeled standard beads. The number of free CD14 molecules per monocyte in the presence of 10, 3.33, 0.73, 0.25 and 0.041 μg/ml mAb was 0, 13 100, 49 300, 97 700 and 165 900. Stimulation of these partially blocked monocytes with 0.1, 1, 10 and 100 ng/ml ReLPS in the presence of 3% human serum revealed that already 13 100 and 97 700 CD14 molecules provided a maximal Tumor necrosis factor α (TNFα) mRNA response using 100 and 10 ng/ml ReLPS, while the activation totally depended on the number of available CD14 molecules in the case of 1 and 0.1 ng/ml ReLPS. Our data imply that the number of CD14 molecules available for LPS-binding influence the cellular response. In the presence of higher concentrations of LPS only fractions of CD14 participate in the cell activation, while the presence of the spare receptors enhance the sensitivity against lower LPS amounts.

Original languageEnglish
Pages (from-to)11-15
Number of pages5
JournalImmunology Letters
Volume93
Issue number1
DOIs
Publication statusPublished - ápr. 30 2004

Fingerprint

Monocytes
Flow Cytometry
Tumor Necrosis Factor-alpha
Monoclonal Antibodies
Cell Membrane
Messenger RNA
Serum

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Antal-Szalmás, P., Poppelier, M. J. J. G., Sümegi, A., Van Der Bruggen, T., Verhoef, J., Van Kessel, K. P. M., & Van Strijp, J. A. G. (2004). Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. Immunology Letters, 93(1), 11-15. https://doi.org/10.1016/j.imlet.2004.01.007

Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. / Antal-Szalmás, P.; Poppelier, Miriam J J G; Sümegi, Andrea; Van Der Bruggen, Tjomme; Verhoef, Jan; Van Kessel, Kok P M; Van Strijp, Jos A G.

In: Immunology Letters, Vol. 93, No. 1, 30.04.2004, p. 11-15.

Research output: Article

Antal-Szalmás, P, Poppelier, MJJG, Sümegi, A, Van Der Bruggen, T, Verhoef, J, Van Kessel, KPM & Van Strijp, JAG 2004, 'Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations', Immunology Letters, vol. 93, no. 1, pp. 11-15. https://doi.org/10.1016/j.imlet.2004.01.007
Antal-Szalmás P, Poppelier MJJG, Sümegi A, Van Der Bruggen T, Verhoef J, Van Kessel KPM et al. Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. Immunology Letters. 2004 ápr. 30;93(1):11-15. https://doi.org/10.1016/j.imlet.2004.01.007
Antal-Szalmás, P. ; Poppelier, Miriam J J G ; Sümegi, Andrea ; Van Der Bruggen, Tjomme ; Verhoef, Jan ; Van Kessel, Kok P M ; Van Strijp, Jos A G. / Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations. In: Immunology Letters. 2004 ; Vol. 93, No. 1. pp. 11-15.
@article{4d0c732e80fb436eabe48fa2ee57037a,
title = "Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations",
abstract = "Human monocytes express on their plasma membrane relatively large number of CD14 molecules, known to play a crucial role in the lipopolisaccharide (LPS)-mediated cellular activation. Indirect data (J. Biol. Chem. 270 (1995) 9904) suggest that not all of these CD14 molecules participate in LPS-signaling, but the importance of these spare receptors and the exact number of CD14 involved in activation upon different LPS-stimuli is not known. Using different concentrations of a blocking anti-CD14 monoclonal antibody (mAb 60bca) we created monocytes with graded amounts of CD14. The exact number of occupied and free receptors was quantitated by flow cytometry and special mAb-labeled standard beads. The number of free CD14 molecules per monocyte in the presence of 10, 3.33, 0.73, 0.25 and 0.041 μg/ml mAb was 0, 13 100, 49 300, 97 700 and 165 900. Stimulation of these partially blocked monocytes with 0.1, 1, 10 and 100 ng/ml ReLPS in the presence of 3{\%} human serum revealed that already 13 100 and 97 700 CD14 molecules provided a maximal Tumor necrosis factor α (TNFα) mRNA response using 100 and 10 ng/ml ReLPS, while the activation totally depended on the number of available CD14 molecules in the case of 1 and 0.1 ng/ml ReLPS. Our data imply that the number of CD14 molecules available for LPS-binding influence the cellular response. In the presence of higher concentrations of LPS only fractions of CD14 participate in the cell activation, while the presence of the spare receptors enhance the sensitivity against lower LPS amounts.",
keywords = "CD14, GAPDH, glyceraldehyde phosphate dehydrogenase, glycosyl-phosphatidyl- inositol, GPI, LBP, lipopolisaccharide, LPS, LPS-binding protein, mAb, monoclonal antibody, NHS, normal human serum, TLR, TNFα, toll-like recepor, Tumor necrosis factor α",
author = "P. Antal-Szalm{\'a}s and Poppelier, {Miriam J J G} and Andrea S{\"u}megi and {Van Der Bruggen}, Tjomme and Jan Verhoef and {Van Kessel}, {Kok P M} and {Van Strijp}, {Jos A G}",
year = "2004",
month = "4",
day = "30",
doi = "10.1016/j.imlet.2004.01.007",
language = "English",
volume = "93",
pages = "11--15",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations

AU - Antal-Szalmás, P.

AU - Poppelier, Miriam J J G

AU - Sümegi, Andrea

AU - Van Der Bruggen, Tjomme

AU - Verhoef, Jan

AU - Van Kessel, Kok P M

AU - Van Strijp, Jos A G

PY - 2004/4/30

Y1 - 2004/4/30

N2 - Human monocytes express on their plasma membrane relatively large number of CD14 molecules, known to play a crucial role in the lipopolisaccharide (LPS)-mediated cellular activation. Indirect data (J. Biol. Chem. 270 (1995) 9904) suggest that not all of these CD14 molecules participate in LPS-signaling, but the importance of these spare receptors and the exact number of CD14 involved in activation upon different LPS-stimuli is not known. Using different concentrations of a blocking anti-CD14 monoclonal antibody (mAb 60bca) we created monocytes with graded amounts of CD14. The exact number of occupied and free receptors was quantitated by flow cytometry and special mAb-labeled standard beads. The number of free CD14 molecules per monocyte in the presence of 10, 3.33, 0.73, 0.25 and 0.041 μg/ml mAb was 0, 13 100, 49 300, 97 700 and 165 900. Stimulation of these partially blocked monocytes with 0.1, 1, 10 and 100 ng/ml ReLPS in the presence of 3% human serum revealed that already 13 100 and 97 700 CD14 molecules provided a maximal Tumor necrosis factor α (TNFα) mRNA response using 100 and 10 ng/ml ReLPS, while the activation totally depended on the number of available CD14 molecules in the case of 1 and 0.1 ng/ml ReLPS. Our data imply that the number of CD14 molecules available for LPS-binding influence the cellular response. In the presence of higher concentrations of LPS only fractions of CD14 participate in the cell activation, while the presence of the spare receptors enhance the sensitivity against lower LPS amounts.

AB - Human monocytes express on their plasma membrane relatively large number of CD14 molecules, known to play a crucial role in the lipopolisaccharide (LPS)-mediated cellular activation. Indirect data (J. Biol. Chem. 270 (1995) 9904) suggest that not all of these CD14 molecules participate in LPS-signaling, but the importance of these spare receptors and the exact number of CD14 involved in activation upon different LPS-stimuli is not known. Using different concentrations of a blocking anti-CD14 monoclonal antibody (mAb 60bca) we created monocytes with graded amounts of CD14. The exact number of occupied and free receptors was quantitated by flow cytometry and special mAb-labeled standard beads. The number of free CD14 molecules per monocyte in the presence of 10, 3.33, 0.73, 0.25 and 0.041 μg/ml mAb was 0, 13 100, 49 300, 97 700 and 165 900. Stimulation of these partially blocked monocytes with 0.1, 1, 10 and 100 ng/ml ReLPS in the presence of 3% human serum revealed that already 13 100 and 97 700 CD14 molecules provided a maximal Tumor necrosis factor α (TNFα) mRNA response using 100 and 10 ng/ml ReLPS, while the activation totally depended on the number of available CD14 molecules in the case of 1 and 0.1 ng/ml ReLPS. Our data imply that the number of CD14 molecules available for LPS-binding influence the cellular response. In the presence of higher concentrations of LPS only fractions of CD14 participate in the cell activation, while the presence of the spare receptors enhance the sensitivity against lower LPS amounts.

KW - CD14

KW - GAPDH

KW - glyceraldehyde phosphate dehydrogenase

KW - glycosyl-phosphatidyl- inositol

KW - GPI

KW - LBP

KW - lipopolisaccharide

KW - LPS

KW - LPS-binding protein

KW - mAb

KW - monoclonal antibody

KW - NHS

KW - normal human serum

KW - TLR

KW - TNFα

KW - toll-like recepor

KW - Tumor necrosis factor α

UR - http://www.scopus.com/inward/record.url?scp=2342506491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342506491&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2004.01.007

DO - 10.1016/j.imlet.2004.01.007

M3 - Article

C2 - 15134893

AN - SCOPUS:2342506491

VL - 93

SP - 11

EP - 15

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1

ER -